DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Maluf FC. et al
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus APA plus AAP in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)..
ASCO 2020 Abstract 5505
Access:
We do not assume any responsibility for the contents of the web pages of other providers.